Published in J Mol Biol on May 10, 2007
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. EMBO J (2008) 2.36
The CDK9 tail determines the reaction pathway of positive transcription elongation factor b. Structure (2012) 0.87
Efficient transcription through an intron requires the binding of an Sm-type U1 snRNP with intact stem loop II to the splice donor. Nucleic Acids Res (2010) 0.86
Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction. Antimicrob Agents Chemother (2012) 0.84
Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat. Retrovirology (2008) 0.84
A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription. Retrovirology (2014) 0.79
Tetartohedral twinning could happen to you too. Acta Crystallogr D Biol Crystallogr (2012) 0.77
The folding competence of HIV-1 Tat mediated by interaction with TAR RNA. RNA Biol (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
SHELXL: high-resolution refinement. Methods Enzymol (1997) 43.04
Improved R-factors for diffraction data analysis in macromolecular crystallography. Nat Struct Biol (1997) 25.74
Likelihood-enhanced fast rotation functions. Acta Crystallogr D Biol Crystallogr (2004) 23.86
A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell (1998) 10.14
Controlling the elongation phase of transcription with P-TEFb. Mol Cell (2006) 9.95
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature (1995) 9.03
Breaking barriers to transcription elongation. Nat Rev Mol Cell Biol (2006) 8.18
Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J Biol Chem (1996) 6.78
Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature (1996) 6.67
Recycling the cell cycle: cyclins revisited. Cell (2004) 6.04
Identification of multiple cyclin subunits of human P-TEFb. Genes Dev (1998) 4.73
Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem (1994) 4.70
The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev (1998) 4.38
Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol Cell (2003) 4.27
Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J (1998) 4.08
The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol (1999) 3.83
Tackling Tat. J Mol Biol (1999) 3.13
Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J (1998) 3.05
MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner. Mol Cell Biol (2003) 2.90
A structural perspective of CTD function. Genes Dev (2005) 2.85
Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nat Med (2002) 2.82
The RNA polymerase II elongation complex. Annu Rev Biochem (2003) 2.76
Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol Cell Biol (2004) 2.49
Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186. J Biol Chem (2005) 2.24
Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Res (2007) 2.02
Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc Natl Acad Sci U S A (1999) 1.87
Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat. J Biol Chem (2005) 1.71
Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology (1999) 1.70
Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol Cell Biol (2002) 1.68
Regulation of polymerase II transcription by 7SK snRNA: two distinct RNA elements direct P-TEFb and HEXIM1 binding. Mol Cell Biol (2006) 1.59
The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene (2005) 1.54
TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication. Proc Natl Acad Sci U S A (2002) 1.44
CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. Mol Cell Biol (2003) 1.42
Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol Cell (2003) 1.42
The cyclin box fold: protein recognition in cell-cycle and transcription control. Trends Biochem Sci (1997) 1.34
The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles. EMBO J (2005) 1.31
Biochemical characterization of the diaphanous autoregulatory interaction in the formin homology protein FHOD1. J Biol Chem (2005) 1.30
Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA. J Mol Biol (2004) 1.29
HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy. J Biol Chem (2006) 1.26
HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1. J Biol Chem (2000) 1.26
Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1. J Virol (2000) 1.17
The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition. J Biol Chem (2006) 1.14
The structure of cyclin H: common mode of kinase activation and specific features. EMBO J (1997) 1.08
Structure of the mediator subunit cyclin C and its implications for CDK8 function. J Mol Biol (2005) 0.97
Structural basis for CDK6 activation by a virus-encoded cyclin. Nat Struct Biol (2002) 0.93
Evidence for conformational flexibility in the Tat-TAR recognition motif of cyclin T1. Virology (2004) 0.93
A minimal chimera of human cyclin T1 and tat binds TAR and activates human immunodeficiency virus transcription in murine cells. J Virol (2002) 0.87
Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9. J Mol Biol (2006) 0.86
Canine cyclin T1 rescues equine infectious anemia virus tat trans-activation in human cells. Virology (2000) 0.82
Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell (2003) 5.44
Splicing regulates NAD metabolite binding to histone macroH2A. Nat Struct Mol Biol (2005) 3.40
A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat Struct Mol Biol (2009) 3.26
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. Cancer Cell (2009) 2.73
FMNL2 drives actin-based protrusion and migration downstream of Cdc42. Curr Biol (2012) 2.18
The control of HIV transcription: keeping RNA polymerase II on track. Cell Host Microbe (2011) 2.05
Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Res (2007) 2.02
Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution. J Biol Chem (2009) 1.96
The human formin FHOD1 contains a bipartite structure of FH3 and GTPase-binding domains required for activation. Structure (2008) 1.85
Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein. J Biol Chem (2012) 1.83
The RNA polymerase II carboxy-terminal domain (CTD) code. Chem Rev (2013) 1.82
Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat. J Biol Chem (2005) 1.71
Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol Cell Biol (2002) 1.68
Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE. EMBO J (2002) 1.64
Fifteen formins for an actin filament: a molecular view on the regulation of human formins. Biochim Biophys Acta (2010) 1.56
The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene (2005) 1.54
The FACT Spt16 "peptidase" domain is a histone H3-H4 binding module. Proc Natl Acad Sci U S A (2008) 1.50
Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency. Hum Mutat (2012) 1.50
Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition. Nat Commun (2012) 1.49
Catalytic core of a membrane-associated eukaryotic polyphosphate polymerase. Science (2009) 1.44
Acetylation of RNA polymerase II regulates growth-factor-induced gene transcription in mammalian cells. Mol Cell (2013) 1.40
Pillars Article: Promiscuous Gene Expression in Medullary Thymic Epithelial Cells Mirrors the Peripheral Self. Nat. Immunol. 2001. 2: 1032-1039. J Immunol (2016) 1.40
U2AF-homology motif interactions are required for alternative splicing regulation by SPF45. Nat Struct Mol Biol (2007) 1.38
Structural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAV. Nat Struct Mol Biol (2008) 1.36
Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. J Infect Dis (2010) 1.34
A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep (2006) 1.33
Structural insights into the target specificity of plant invertase and pectin methylesterase inhibitory proteins. Plant Cell (2004) 1.33
The C2 domain of SynGAP is essential for stimulation of the Rap GTPase reaction. EMBO Rep (2008) 1.31
Biochemical characterization of the diaphanous autoregulatory interaction in the formin homology protein FHOD1. J Biol Chem (2005) 1.30
Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA. Chem Biol (2002) 1.30
HIV-1 Nef membrane association depends on charge, curvature, composition and sequence. Nat Chem Biol (2009) 1.29
Biochemical indication for myristoylation-dependent conformational changes in HIV-1 Nef. Biochemistry (2006) 1.24
Pyrophosphate-producing protein dephosphorylation by HPr kinase/phosphorylase: a relic of early life? Proc Natl Acad Sci U S A (2002) 1.23
Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef. Virology (2006) 1.21
The Diaphanous-related Formin FHOD1 associates with ROCK1 and promotes Src-dependent plasma membrane blebbing. J Biol Chem (2008) 1.20
Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription. J Biol Chem (2013) 1.17
Human Lsg1 defines a family of essential GTPases that correlates with the evolution of compartmentalization. BMC Biol (2005) 1.15
P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA. J Biol Chem (2002) 1.15
HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. PLoS One (2010) 1.14
Conformation of full-length Bruton tyrosine kinase (Btk) from synchrotron X-ray solution scattering. EMBO J (2003) 1.13
Conformational states of human rat sarcoma (Ras) protein complexed with its natural ligand GTP and their role for effector interaction and GTP hydrolysis. J Biol Chem (2010) 1.12
Crystal structure and nuclear magnetic resonance analyses of the SAND domain from glucocorticoid modulatory element binding protein-1 reveals deoxyribonucleic acid and zinc binding regions. Mol Endocrinol (2003) 1.10
Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb. Proc Natl Acad Sci U S A (2007) 1.09
Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains. Retrovirology (2007) 1.08
Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation. Hum Mutat (2008) 1.07
Dimerization and protein binding specificity of the U2AF homology motif of the splicing factor Puf60. J Biol Chem (2008) 1.06
Biophysical analysis of the interaction of Rab6a GTPase with its effector domains. J Biol Chem (2008) 1.05
Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat. Mol Cell Biol (2014) 1.03
Structural basis for the redox control of plant glutamate cysteine ligase. J Biol Chem (2006) 1.03
The Leishmania tarentolae exosome: purification and structural analysis by electron microscopy. Mol Biochem Parasitol (2008) 1.03
Conformation of the dileucine-based sorting motif in HIV-1 Nef revealed by intermolecular domain assembly. Traffic (2011) 1.02
HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb. Cancer Res (2008) 1.01
When the lymphocyte loses its clothes. Immunity (2003) 0.99
Structure of the full-length HPr kinase/phosphatase from Staphylococcus xylosus at 1.95 A resolution: Mimicking the product/substrate of the phospho transfer reactions. Proc Natl Acad Sci U S A (2002) 0.97
Structure of the full-length enzyme I of the phosphoenolpyruvate-dependent sugar phosphotransferase system. J Biol Chem (2006) 0.97
The sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex. J Mol Biol (2006) 0.97
Release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein (snRNP) activates hexamethylene bisacetamide-inducible protein (HEXIM1) transcription. J Biol Chem (2014) 0.96
Interaction of propionylated and butyrylated histone H3 lysine marks with Brd4 bromodomains. Angew Chem Int Ed Engl (2010) 0.96
FHOD1 is a combined actin filament capping and bundling factor that selectively associates with actin arcs and stress fibers. J Cell Sci (2013) 0.96
Structure and function of the hetero-oligomeric cysteine synthase complex in plants. J Biol Chem (2010) 0.95
DLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domain. Mol Biol Cell (2009) 0.94
Molecular design, functional characterization and structural basis of a protein inhibitor against the HIV-1 pathogenicity factor Nef. PLoS One (2011) 0.94
Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP. J Mol Biol (2003) 0.93
The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2. J Mol Biol (2008) 0.93
Reacquisition of Nef-mediated tetherin antagonism in a single in vivo passage of HIV-1 through its original chimpanzee host. Cell Host Microbe (2012) 0.92
Complex formation and light activation in membrane-embedded sensory rhodopsin II as seen by solid-state NMR spectroscopy. Structure (2010) 0.92
The redox switch of gamma-glutamylcysteine ligase via a reversible monomer-dimer transition is a mechanism unique to plants. Plant J (2008) 0.91
Mechanism of Substrate and Inhibitor Binding of Rhodobacter capsulatus Xanthine Dehydrogenase. J Biol Chem (2008) 0.91
Farnesylation of the SNARE protein Ykt6 increases its stability and helical folding. J Mol Biol (2008) 0.91
Amino acids of the bacterial toxin SopE involved in G nucleotide exchange on Cdc42. J Biol Chem (2003) 0.91
NMR spectroscopic investigation of early events in IAPP amyloid fibril formation. Chembiochem (2009) 0.90
Inhibition and termination of physiological responses by GTPase activating proteins. Physiol Rev (2012) 0.89
Oligomerization of the diaphanous-related formin FHOD1 requires a coiled-coil motif critical for its cytoskeletal and transcriptional activities. FEBS Lett (2005) 0.89
Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression. J Virol (2002) 0.88
Extracellular HIV-1 Nef increases migration of monocytes. Exp Cell Res (2006) 0.88
Enhancing endosomal escape of transduced proteins by photochemical internalisation. PLoS One (2012) 0.88
Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection. J Virol (2012) 0.88
Specificity of Hexim1 and Hexim2 complex formation with cyclin T1/T2, importin alpha and 7SK snRNA. J Mol Biol (2009) 0.88
HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. PLoS One (2011) 0.87
A minimal chimera of human cyclin T1 and tat binds TAR and activates human immunodeficiency virus transcription in murine cells. J Virol (2002) 0.87
Structural insights into the pH-controlled targeting of plant cell-wall invertase by a specific inhibitor protein. Proc Natl Acad Sci U S A (2010) 0.87
Thioredoxin as a fusion tag for carrier-driven crystallization. Protein Sci (2008) 0.87
Separate domains of fission yeast Cdk9 (P-TEFb) are required for capping enzyme recruitment and primed (Ser7-phosphorylated) Rpb1 carboxyl-terminal domain substrate recognition. Mol Cell Biol (2012) 0.87
Identification of a highly conserved valine-glycine-phenylalanine amino acid triplet required for HIV-1 Nef function. Retrovirology (2012) 0.87
Crystal Structure of the alpha-Actinin Rod: Four Spectrin Repeats Forming a Thight Dimer. Cell Mol Biol Lett (2001) 0.86
The invertase inhibitor Nt-CIF from tobacco: a highly thermostable four-helix bundle with an unusual N-terminal extension. J Mol Biol (2004) 0.86
Migratory potential of rheumatoid arthritis synovial fibroblasts: additional perspectives. Cell Cycle (2010) 0.85
Comparison of design strategies for promotion of beta-peptide 14-helix stability in water. Chembiochem (2008) 0.85
Molecular mechanisms of HIV latency. J Clin Invest (2016) 0.85
Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat. Retrovirology (2008) 0.84
Expression, purification and preliminary crystallographic characterization of a novel segment from the neurofibromatosis type 1 protein. Acta Crystallogr D Biol Crystallogr (2004) 0.84
Genetic analysis of the structure and function of 7SK small nuclear ribonucleoprotein (snRNP) in cells. J Biol Chem (2014) 0.83